Chronic heart failure in adults: summary of updated NICE guidance by Real, J, Cowles, E, Wierzbicki, A, Committee, o

Utilization of sterol carrier protein-2 by phytanoyl-CoA 2-hydroxylase in the peroxisomal alpha oxidation of phytanic acid. by Mukherji, M, Kershaw, N, Schofield, C, Wierzbicki, A, Lloyd, MD

Refsum's disease: a peroxisomal disorder affecting phytanic acid alpha-oxidation. by Wierzbicki, A, Lloyd, MD, Schofield, C, Feher, MD, Gibberd, F

The chemical biology of branched-chain lipid metabolism. by Mukherji, M, Schofield, C, Wierzbicki, A, Jansen, G, Wanders, R, Lloyd, MD

Role of phytanoyl-CoA 2-hydroxylase in phytanic acid metabolism. by Lloyd, MD, Mukherji, M, Kershaw, N, Chien, W, Wierzbicki, A, Schofield, C

Unnatural co-substrate-based rescue of enzyme activity in Refsum's disease resulting from mutations in R275 of phytanoyl-CoA hydroxylase. by Lloyd, MD, Mukherji, M, Kershaw, N, MacKinnon, C, Schofield, C, Wierzbicki, A

Structure-function analysis of phytanoyl-CoA 2-hydroxylase mutations causing Refsum's disease. by Mukherji, M, Chien, W, Kershaw, N, Clifton, I, Schofield, C, Wierzbicki, A, Lloyd, MD

'Chemical co-substrate rescue' of phytanoyl-CoA 2-hydroxylase mutants causing Refsum's Disease by Mukherji, M, Kershaw, N, MacKinnon, C, Clifton, I, Wierzbicki, A, Schofield, C, Lloyd, MD

Studies on phytanoyl-CoA 2-hydroxylase and synthesis of phytanoyl-coenzyme A. by Kershaw, N, Mukherji, M, MacKinnon, C, Claridge, T, Odell, B, Wierzbicki, A, Lloyd, MD, Schofield, C

Mortality in treated heterozygous familial hypercholesterolaemia: implications for clinical management. Scientific Steering Committee on behalf of the Simon Broome Register Group. by Neil, H, Betteridge, D, Broome, K, Durrington, P, Hawkins, M, Humphries, SE, Mann, J, Miller, J, Thompson, G, Thorogood, M, Potok, M, Mathews, F, Arnsten, K, Flemming, S, Betteridge, D, Durrington, P, Alkeles, R, Finnie, R, Galton, D, Hillson, R, Hughes, E, Laker, M, Lewis, B, Wierzbicki, A, Lorimer, R